These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 6140426)
1. Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin. O'Brien AD; Chen ME; Holmes RK; Kaper J; Levine MM Lancet; 1984 Jan; 1(8368):77-8. PubMed ID: 6140426 [TBL] [Abstract][Full Text] [Related]
2. Shiga toxin--an expanding role in the pathogenesis of infectious diseases. Cantey JR J Infect Dis; 1985 May; 151(5):766-71. PubMed ID: 3886803 [No Abstract] [Full Text] [Related]
3. Enzyme-linked immunosorbent assay to detect Shiga toxin of Shigella dysenteriae and related toxins. Kongmuang U; Honda T; Miwatani T J Clin Microbiol; 1987 Jan; 25(1):115-8. PubMed ID: 3539985 [TBL] [Abstract][Full Text] [Related]
4. The relation between production of cytotoxin and clinical features in shigellosis. Prado D; Cleary TG; Pickering LK; Ericsson CD; Bartlett AV; DuPont HL; Johnson PC J Infect Dis; 1986 Jul; 154(1):149-55. PubMed ID: 3519788 [TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin. Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916 [TBL] [Abstract][Full Text] [Related]
6. Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. Okuda J; Kurazono H; Takeda Y Microb Pathog; 1995 Mar; 18(3):167-72. PubMed ID: 7565011 [TBL] [Abstract][Full Text] [Related]
7. Non-O1 Vibrio cholerae produces two newly identified toxins related to Vibrio parahaemolyticus haemolysin and Escherichia coli heat-stable enterotoxin. Honda T; Arita M; Takeda T; Yoh M; Miwatani T Lancet; 1985 Jul; 2(8447):163-4. PubMed ID: 2862364 [No Abstract] [Full Text] [Related]
8. Toxin profiles of Vibrio cholerae non-O1 from environmental sources in Calcutta, India. Nair GB; Oku Y; Takeda Y; Ghosh A; Ghosh RK; Chattopadhyay S; Pal SC; Kaper JB; Takeda T Appl Environ Microbiol; 1988 Dec; 54(12):3180-2. PubMed ID: 3223774 [TBL] [Abstract][Full Text] [Related]
9. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin. Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402 [TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin. Qadri F; Azim T; Hossain A; Islam D; Mondal G; Faruque SM; Albert MJ Adv Exp Med Biol; 1995; 371B():923-6. PubMed ID: 7502927 [No Abstract] [Full Text] [Related]
11. From the National Institute of Allergy and Infectious Diseases. Summary of the 25th United States-Japan Joint Conference on cholera and related diarrheal diseases. Spriggs DR; Sack RB J Infect Dis; 1990 Sep; 162(3):584-90. PubMed ID: 2201739 [No Abstract] [Full Text] [Related]
12. Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B. Griffin DE; Gemski P Infect Immun; 1983 Apr; 40(1):425-8. PubMed ID: 6299964 [TBL] [Abstract][Full Text] [Related]
13. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins. O'Brien AD; Laveck GD Infect Immun; 1982 Mar; 35(3):1151-4. PubMed ID: 7040247 [TBL] [Abstract][Full Text] [Related]
14. Production of Shiga toxin and other cytotoxins by serogroups of Shigella. Bartlett AV; Prado D; Cleary TG; Pickering LK J Infect Dis; 1986 Dec; 154(6):996-1002. PubMed ID: 3537154 [TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of an extracellular secretogenic non-membrane-damaging cytotoxin produced by clinical strains of Vibrio cholerae non-O1. Saha PK; Koley H; Nair GB Infect Immun; 1996 Aug; 64(8):3101-8. PubMed ID: 8757840 [TBL] [Abstract][Full Text] [Related]
16. Lactobacillus acidophilus attenuates toxin production by Vibrio cholerae and shigella dysenteriae following intestinal epithelial cells infection. Alamdary SZ; Bakhshi B Microb Pathog; 2020 Dec; 149():104543. PubMed ID: 33010360 [TBL] [Abstract][Full Text] [Related]
17. [Diarrhea, dysentery, cholera, new frontiers?]. Niel L; Coue JC; Mérouze F Med Trop (Mars); 1994; 54(4):375-6. PubMed ID: 7746137 [No Abstract] [Full Text] [Related]
18. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery. Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317 [TBL] [Abstract][Full Text] [Related]
19. [Bacterial diversity during the cholera epidemic in Dakar, Senegal (1995-1996)]. Sow AI; Cissé MF; Gaye M; Kébé A; Sy OK; Dia NM; Komo A Bull Soc Pathol Exot; 1997; 90(3):160-1. PubMed ID: 9410248 [TBL] [Abstract][Full Text] [Related]
20. Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence. Neill RJ; Gemski P; Formal SB; Newland JW J Infect Dis; 1988 Oct; 158(4):737-41. PubMed ID: 3049838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]